affiliate disclosure · We earn affiliate commission on some vendor links. Audits, scores, and rankings are independent — vendors do not pay for placement and do not see drafts. read more →
Retatrutide vs Tirzepatide
Two compounds, mechanism by mechanism. Where they overlap, where they don't, and which vendors stock each.
§ 01
Mechanism
retatrutide
Retatrutide
LY3437943GLP-3triple-G
Triple agonist of GLP-1, GIP, and glucagon receptors. Eli Lilly's Phase 3 candidate (TRIUMPH program).
Full guide →vs
tirzepatide
Tirzepatide
MounjaroZepbound
Dual GLP-1 / GIP receptor agonist. FDA-approved as Mounjaro (T2D) and Zepbound (obesity).
Full guide →§ 02
Key facts
§ 03
Use-case overlap
only retatrutide
- metabolic dysfunction
- fatty liver
both
- weight loss
only tirzepatide
- type 2 diabetes
§ 04
Where to buy
§ 05
Sources
- [01]Triple–Hormone-Receptor Agonist Retatrutide for Obesity (NEJM)· Retatrutide
- [02]Lilly TRIUMPH Phase 3 announcement· Retatrutide
- [03]Tirzepatide once weekly for the treatment of obesity (NEJM)· Tirzepatide
read next
Other peptide matchups
the roundup · monthly
Receipts in your inbox. Once a month.
New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.
14,200 subscribers· 0 sponsored items· 11 issues since launch